Li et al. demonstrated that the induction of hepatic CYP7A1 had the potential to prevent obesity, fatty liver, and insulin resistance induced by a high-fat diet, thereby presenting a promising therapeutic alternative for metabolic disorders in humans [36]. Here, CYP7A1 is linked to obesity due to melanocortin 4 receptor deficiency.